Page 71 - AN-3-2
P. 71
Advanced Neurology Inflammation in diabetic stroke: Treatment target
16. Patoulias DI, Boulmpou A, Teperikidis E, et al. study. BMC Endocr Disord. 2020;20(1):31.
Cardiovascular efficacy and safety of dipeptidyl peptidase-4 doi: 10.1186/s12902-020-0511-z
inhibitors: A meta-analysis of cardiovascular outcome trials.
World J Cardiol. 2021;13(10):585-592. 27. Zhao S, Kusminski CM, Elmquist JK, Scherer PE. Leptin:
Less is more. Diabetes. 2020;69(5):823-829.
doi: 10.4330/wjc.v13.i10.585
doi: 10.2337/dbi19-0018
17. Schmidt AM. Diabetes mellitus and cardiovascular disease.
Arterioscler Thromb Vasc Biol. 2019;39(4):558-568. 28. Cioffi JA, Shafer AW, Zupancic TJ, et al. Novel B219/OB
receptor isoforms: Possible role of leptin in hematopoiesis
doi: 10.1161/ATVBAHA.119.310961
and reproduction. Nat Med. 1996;2(5):585-589.
18. Xia C, Goud A, D’Souza J, et al. DPP4 inhibitors and doi: 10.1038/nm0596-585
cardiovascular outcomes: Safety on heart failure. Heart Fail
Rev. 2017;22(3):299-304. 29. Sanchez-Margalet V, Martin-Romero C, Santos-Alvarez J,
Goberna R, Najib S, Gonzalez-Yanes C. Role of leptin as an
doi: 10.1007/s10741-017-9617-4
immunomodulator of blood mononuclear cells: Mechanisms
19. Frak W, Hajdys J, Radzioch E, et al. Cardiovascular diseases: of action. Clin Exp Immunol. 2003;133(1):11-19.
Therapeutic potential of SGLT-2 inhibitors. Biomedicines. doi: 10.1046/j.1365-2249.2003.02190.x
2023;11(7):2085.
30. Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes
doi: 10.3390/biomedicines11072085
aggregation of human platelets via the long form of its
20. Huang K, Luo X, Liao B, Li G, Feng J. Insights into SGLT2 receptor. Diabetes. 1999;48(2):426-429.
inhibitor treatment of diabetic cardiomyopathy: Focus on doi: 10.2337/diabetes.48.2.426
the mechanisms. Cardiovasc Diabetol. 2023;22(1):86.
31. Abderrazak A, Syrovets T, Couchie D, et al. NLRP3
doi: 10.1186/s12933-023-01816-5
inflammasome: From a danger signal sensor to a regulatory
21. Gourdy P, Darmon P, Dievart F, Halimi JM, Guerci B. node of oxidative stress and inflammatory diseases. Redox
Combining glucagon-like peptide-1 receptor agonists Biol. 2015;4:296-307.
(GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors doi: 10.1016/j.redox.2015.01.008
(SGLT2is) in patients with type 2 diabetes mellitus (T2DM).
Cardiovasc Diabetol. 2023;22(1):79. 32. Look AHEAD Research Group, Gregg E, Jakicic J, et al.
Association of the magnitude of weight loss and changes
doi: 10.1186/s12933-023-01798-4
in physical fitness with long-term cardiovascular disease
22. Eckel RH, Bornfeldt KE, Goldberg IJ. Cardiovascular outcomes in overweight or obese people with type 2 diabetes:
disease in diabetes, beyond glucose. Cell Metab. A post-hoc analysis of the Look AHEAD randomised clinical
2021;33(8):1519-1545. trial. Lancet Diabetes Endocrinol. 2016;4(11):913-921.
doi: 10.1016/j.cmet.2021.07.001 doi: 10.1016/S2213-8587(16)30162-0
23. Paridari P, Jabermoradi S, Gholamzadeh R, et al. Can 33. Zhao S, Zhu Y, Schultz RD, et al. Partial leptin reduction as
metformin use reduce the risk of stroke in diabetic patients? an insulin sensitization and weight loss strategy. Cell Metab.
A systematic review and meta-analysis. Diabetes Metab 2019;30(4):706-719.e6.
Syndr. Feb 2023;17(2):102721.
doi: 10.1016/j.cmet.2019.08.005
doi: 10.1016/j.dsx.2023.102721
34. Civitarese AE, Jenkinson CP, Richardson D, et al.
24. Nakatsuji H, Kobayashi H, Kishida K, et al. Binding Adiponectin receptors gene expression and insulin
of adiponectin and C1q in human serum, and clinical sensitivity in non-diabetic Mexican Americans with or
significance of the measurement of C1q-adiponectin/total without a family history of Type 2 diabetes. Diabetologia.
adiponectin ratio. Metabolism. 2013;62(1):109-120. 2004;47(5):816-820.
doi: 10.1016/j.metabol.2012.06.006 doi: 10.1007/s00125-004-1359-x
25. Gairolla J, Kler R, Modi M, Khurana D. Leptin and 35. Bluher M, Bullen JW Jr., Lee JH, et al. Circulating adiponectin
adiponectin: pathophysiological role and possible and expression of adiponectin receptors in human skeletal
therapeutic target of inflammation in ischemic stroke. Rev muscle: Associations with metabolic parameters and
Neurosci. 2017;28(3):295-306. insulin resistance and regulation by physical training. J Clin
Endocrinol Metab. 2006;91(6):2310-2316.
doi: 10.1515/revneuro-2016-0055
doi: 10.1210/jc.2005-2556
26. Bidulescu A, Dinh PC Jr., Sarwary S, et al. Associations of
leptin and adiponectin with incident type 2 diabetes and 36. Bodles AM, Banga A, Rasouli N, Ono F, Kern PA, Owens RJ.
interactions among African Americans: The Jackson heart Pioglitazone increases secretion of high-molecular-weight
Volume 3 Issue 2 (2024) 10 doi: 10.36922/an.1694

